CHAIR
:
SPEAKER
(S):
Tracy Tsuetaki, MBA,MS (SPKNON), Group President, Life Sciences, OptumInsight, United States
Sean Darcy, JR, BSN,RN (SPKNON), Senior Director, Global Patient Safety and Global Medical Information, Vertex Pharmaceuticals, United States
Pamela M. Williamson, MBA,RAC (SPKNON), Senior Vice President, Global Head, Regulatory Affairs and Compliance, Genzyme Corporation, A Sanofi Company, United States
Andrew Storey,
(SPKNON), Head, Regulatory Affairs Area and Affiliate Strategy, US/Canada,
AbbVie, United States
Andrew has been with Cangene since 1986 and provides leadership for the clinical development and licensing of all Cangene's drugs, including their Biodefense drugs: Vaccinia immune globulin, Anthrax imune globulin and Botulism anti-toxin.
|
Description
This forum will present examples of regulatory outsourcing partnerships and discuss trends in this area. A panel of experts will provide their interpretation of data from results of a global regulatory outsourcing survey and share best practices.